NCT06179524
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
- Locations
-
- Hematology Hospital of the Chinese Academy of Medical Sciences Tianjin, China
Clinical trial condition
Refractory B-cell Acute Lymphoblastic Leukemia
Explore clinical trials studying Refractory B-cell Acute Lymphoblastic Leukemia. Study availability and eligibility vary by location and protocol.
3 public trials
1 recruiting study
Refractory B-cell Acute Lymphoblastic Leukemia trial results
Completed
Study of UCART19 in Pediatric Patients With Relapsed/Refractory B Acute Lymphoblastic Leukemia
NCT02808442
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
- Locations
-
- Children's Hospital Los Angeles Los Angeles, California, United States
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
- University of Texas Southwestern Medical Center Dallas, Texas, United States
- Hôpital Robert-Debré Paris, France
NCT02228096
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +25 more
- Locations
-
- Childrens Hospital Los Angeles SC Los Angeles, California, United States
- Stanford University Medical Center Palo Alto, California, United States
- Children's Healthcare of Atlanta SC-2 Atlanta, Georgia, United States
- University of Michigan Ann Arbor, Michigan, United States